rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 20 Mar ' 20 Sep ' 19 Sep ' 18 Sep ' 17
Sales 293.51 230.52 193.13 207.79 127.80
Operating profit 52.05 38.65 23.08 34.90 14.20
Interest 2.11 2.94 4.36 3.43 3.82
Gross profit 62.95 35.64 28.73 37.48 10.42
EPS (Rs) 1.11 0.50 0.43 0.64 0.06
Half yearly  results in details
Sep ' 20 Mar ' 20 Sep ' 19 Sep ' 18 Sep ' 17
Other income 13.01 -0.08 10.02 6.02 0.04
Stock adjustment 0.07 -5.74 0.11 -0.68 -0.15
Raw material 137.29 109.24 99.97 97.50 66.48
Power and fuel - - - - -
Employee expenses 25.13 24.78 23.73 23.03 23.06
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 78.97 63.59 46.26 53.05 24.21
Provisions made - - - - -
Depreciation 7.01 6.35 5.30 4.27 7.12
Taxation 10.34 8.91 5.92 7.00 0.83
Net profit / loss 45.59 20.39 17.52 26.21 2.48
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 40.93 40.93 40.93 40.93 40.93
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 17.73 16.77 11.95 16.79 11.11
GPM (%) 20.54 15.46 14.14 17.53 8.15
NPM (%) 14.87 8.85 8.62 12.26 1.94

Mutual Fund Selector

Find the fund that is right for you
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close